Premium
Tano Capital, an Asia-focused alternative asset manager that runs an India-specific fund, has trebled its investment in listed active pharmaceutical ingredients manufacturer Shilpa Medicare Ltd over nine years, VCCircle estimates show. Tano sold 30 lakh shares in the Hyderabad-based API developer for gross proceeds of Rs.153.32 crore on Thursday, stock ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.